Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $38,556 - $84,294
37,800 Added 12.59%
338,100 $447,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.94 $752 - $1,552
-800 Reduced 0.27%
300,300 $309,000
Q1 2022

May 16, 2022

BUY
$1.54 - $3.71 $463,694 - $1.12 Million
301,100 New
301,100 $593,000
Q4 2021

Feb 14, 2022

SELL
$2.58 - $3.91 $875,394 - $1.33 Million
-339,300 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.58 - $3.91 $29,412 - $44,574
-11,400 Reduced 3.25%
339,300 $905,000
Q3 2021

Nov 15, 2021

BUY
$2.77 - $4.05 $971,439 - $1.42 Million
350,700 New
350,700 $1.19 Million
Q3 2021

Nov 15, 2021

SELL
$2.77 - $4.05 $356,499 - $521,235
-128,700 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $220,077 - $532,818
128,700 New
128,700 $493,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $363M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.